Our results also demonstrate a trend towards significance of elevated immunoreactive trypsinogen as a group in patients who developed type 1 diabetes, with ~2.5 times as many of these patient’s results triggering second-tier testing over the general population.
← all excerpts
Immunoreactive Trypsinogen and Free Carnitine Changes on Newborn Screening after Birth in Patients Who Develop Type 1 Diabetes.
1
—
—